Hemab Therapeutics is building a differentiated coagulation franchise targeting underserved rare bleeding disorders. Learn ...
Scientists have launched the first clinical trial to test whether an experimental antiviral pill can prevent Bundibugyo Ebola ...
GENEVA, Switzerland - The first clinical trial is underway of an antiviral drug's effectiveness in people exposed to the ...
PEP, aims to assess the effectiveness of the antiviral obeldesivir in post-exposure prophylaxis, for people who have been in ...
The World Health Organization launched the first clinical trial on Tuesday to test whether an antiviral drug can prevent ...
The Manila Times on MSN
Trial of potential Ebola antiviral under way — WHO
GENEVA, Switzerland — The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the ...
Epidemic continues to spread at unprecedented pace, into new areas, while efforts to control remain insufficient, says ...
Geneva: The first clinical trial is under way of an antiviral drug's effectiveness in people exposed to the deadly Ebola ...
As Pfizer and Moderna have tied off certain threads in their separate webs of mRNA patent litigation, Sanofi has opened a new ...
Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that new data from its research pipeline for HIV treatment and prevention will be presented at the 26th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results